P3.03-007 LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor
Year: 2017
Type: article
Study design: Observational Study
Source: Journal of Thoracic Oncology
Authors: M. Kris, D. Aisner, L. Sholl, L. Berry, M. Rossi, H. Chen, J. Fujimoto, A. Moreira, S. Ramalingam, L. Villaruz, G. Otterson, E. Haura, K. Politi, B. Glisson, J. Cetnar, E. Garon, J. Schiller, S. Waqar, L. Sequist, J. Brahmer, Y. Shyr, K. Kugler, I. Wistuba, B. Johnson, J. Minna, P. Bunn, D. Kwiatkowski
Institutions: Memorial Sloan Kettering Cancer Center, University of Colorado Anschutz, Brigham and Women's Hospital, Vanderbilt University Medical Center, Emory University, The University of Texas MD Anderson Cancer Center, University of Pittsburgh, The Ohio State University Wexner Medical Center, Moffitt Cancer Center, Yale University, Oregon Health & Science University, UCLA Medical Center, The University of Texas Southwestern Medical Center, Washington University in St. Louis, Massachusetts General Hospital, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2767495113